Overview
APYX market data
Price History
APYX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.27 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.42 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.59 – $5.08 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $162.6 · P/B 9.88 · P/S 2.91.
Company news
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga · Jul 13, 2026, 11:41 AM
HC Wainwright & Co. Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $7Benzinga · Jul 13, 2026, 10:12 AM
Apyx Medical Appoints Stavros Vizirgianakis Executive Chairman, Effective June 11Benzinga · Jun 17, 2026, 8:20 PM
8-K filing — Apyx Medical Corp (APYX)SEC EDGAR · Jun 17, 2026, 8:05 PM
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®Globenewswire Inc · May 21, 2026, 12:15 PM
Apyx Medical Publishes New Clinical Data In Aesthetic Surgery Journal Open Forum Highlighting Approach To Improving Cellulite And Skin LaxityBenzinga · May 21, 2026, 12:10 PM
Apyx Medical Announces Publication Of A New Retrospective Investigator-Initiated Study In Plastic And Reconstructive Surgery - Global OpenBenzinga · May 14, 2026, 12:13 PM
Apyx Medical Expands FDA 510(k) Clearance For AYON Body Contouring System To Include Power LiposuctionBenzinga · May 11, 2026, 12:07 PM
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™Globenewswire Inc · May 11, 2026, 12:05 PM